Lostat-H Tablet contains a combination of Losartan 50 mg and Hydrochlorothiazide 12.5 mg, formulated for the management of hypertension. Losartan is an angiotensin II receptor antagonist that selectively blocks the binding of angiotensin II to the AT1 receptor, thereby inhibiting vasoconstriction and aldosterone secretion, which results in vasodilation and reduced blood pressure. Hydrochlorothiazide is a thiazide diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to a decrease in blood volume and peripheral resistance. The synergistic effect of these two agents effectively lowers elevated blood pressure, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Lostat-H is indicated for patients who require combination therapy to achieve adequate blood pressure control when monotherapy is insufficient. It is essential to monitor electrolyte levels, renal function, and blood pressure regularly during treatment. Contraindications include hypersensitivity to any component, anuria, and severe renal or hepatic impairment. Caution is advised in patients with diabetes, gout, or electrolyte imbalances. Lostat-H should be used under medical supervision, adhering to prescribed dosage and monitoring guidelines to optimize therapeutic outcomes and minimize adverse effects.